Long duration of immunotherapy in a STK11 mutated/KRAS wild-type non-small cell lung cancer patient

Thumbnail
View
Author
Domingues, I.
Cedres Perez, Susana
Callejo Perez, Ana
Vivancos Prellezo, Ana
Martínez Marti, Alexandre
Felip Font, Enriqueta ORCID
Date
2020-01
Permanent link
https://hdl.handle.net/11351/6479
DOI
10.1016/j.pulmoe.2019.05.002
ISSN
2531-0437
WOS
000505089100008
PMID
31401029
Share on TwitterShare on FacebookShare on TelegramShare on WhatsappShare on Linkedin

Show full item record
Keywords
Lung cancer; Immunotherapy
Bibliographic citation
Domingues I, Cedres S, Callejo A, Vivancos A, Martinez-Marti A, Felip E. Long duration of immunotherapy in a STK11 mutated/KRAS wild-type non-small cell lung cancer patient. Pulmonology. 2019 Jan;26(1):49–50.
Audience
Professionals
This item appears in following collections

The following license files are associated with this item: